38 results
424B5
VKTX
Viking Therapeutics Inc
1 Mar 24
Prospectus supplement for primary offering
4:13pm
.
Liquidation Preference
In the event that we voluntarily or involuntarily liquidate, dissolve or wind up, the holders of each depositary receipt
424B5
VKTX
Viking Therapeutics Inc
27 Feb 24
Prospectus supplement for primary offering
5:21pm
or involuntarily liquidate, dissolve or wind up, the holders of each depositary receipt will be entitled to the fraction of the liquidation preference accorded
S-3ASR
2ap2 av1ex40v
26 Jul 23
Automatic shelf registration
5:26pm